Initial reporter facility name: (b)(6) medical hospital.Address: (b)(6).The device was not returned and the lot number is unknown; however, based on information received, the most probable cause was identified as a shock during shipping/transportation.Should additional relevant information become available, a supplemental report will be submitted.Prismaflex st150 set c has been temporarily approved for use in the us under emergency use authorization (b)(4) to deliver crrt to treat patients in an acute care environment during the covid-19 pandemic.
|